# Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms

> **NCT02056574** · PHASE2 · WITHDRAWN · sponsor: **NoNO Inc.**

## Conditions studied

- Subarachnoid Hemorrhage
- Ruptured Intracranial Aneurysm

## Interventions

- **DRUG:** NA-1
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02056574
- **Lead sponsor:** NoNO Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-11
- **Primary completion:** 2019-11
- **Final completion:** 2020-04
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02056574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02056574, "Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02056574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*